Abstract
This cross-sectional study evaluates the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and misuse among people with eating disorders in the US.
Cite
CITATION STYLE
APA
Peiper, N. C., Zibbell, J. E., LaJoie, A. S., Wahlang, B., Krishnasamy, S. S., & Levinson, C. A. (2026). Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.1716
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free